cAMPfield
USEntry
2026
Hold
New
Status
Active
Who owns cAMPfield?
cAMPfield is an American Biotech company, currently owned by Novo Holdings since 2026 and Abingworth.
Hand-verified · updated 2026-07-08
Open JSON · CC-BY
Most recent investor
AbingworthAbingworth Bioventures IX · 2023 · VC
2 ownership periods · full history below
Key facts
HQUS
SectorBiotech
StatusActive
Ownership history
2 ownership periods
Active
Novo HoldingsActive
2026 · present(<1yr) · Novo Holdings Seed Investments · 1999 · VC
AbingworthActive
2026 · present(<1yr) · Abingworth Bioventures IX · 2023 · VC
More from Abingworth Bioventures IX
Other portfolio companies in the same fund.
More Abingworth portfolio companies
From the same investor, across funds.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns cAMPfield?
cAMPfield is currently owned by Novo Holdings and Abingworth, through Abingworth Bioventures IX, since 2026.
When did Novo Holdings and 1 other acquire cAMPfield?
Novo Holdings and 1 other acquired cAMPfield in 2026.
Who has owned cAMPfield over time?
cAMPfield has been through 2 private-equity ownership periods: Novo Holdings · via Novo Holdings Seed Investments · since 2026; Abingworth · via Abingworth Bioventures IX · since 2026.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue